GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Book Value per Share

CSPC Pharmaceutical Group (HKSE:01093) Book Value per Share : HK$3.05 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Book Value per Share?

CSPC Pharmaceutical Group's book value per share for the quarter that ended in Dec. 2023 was HK$3.05.

During the past 12 months, CSPC Pharmaceutical Group's average Book Value Per Share Growth Rate was 8.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 16.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 18.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of CSPC Pharmaceutical Group was 54.40% per year. The lowest was -41.70% per year. And the median was 19.30% per year.

CSPC Pharmaceutical Group's current price is HK$6.60. Its book value per share for the quarter that ended in Dec. 2023 was HK$3.05. Hence, today's PB Ratio of CSPC Pharmaceutical Group is 2.16.

During the past 13 years, the highest P/B Ratio of CSPC Pharmaceutical Group was 3.33. The lowest was 1.89. And the median was 2.23.


CSPC Pharmaceutical Group Book Value per Share Historical Data

The historical data trend for CSPC Pharmaceutical Group's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Book Value per Share Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 2.21 2.66 2.83 3.05

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.83 - 2.92 - 3.05

Competitive Comparison of CSPC Pharmaceutical Group's Book Value per Share

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's PB Ratio falls into.



CSPC Pharmaceutical Group Book Value per Share Calculation

CSPC Pharmaceutical Group's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(36,317-0)/11,903
=3.05

CSPC Pharmaceutical Group's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(36,317-0)/11,903
=3.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


CSPC Pharmaceutical Group  (HKSE:01093) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


CSPC Pharmaceutical Group Book Value per Share Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (HKSE:01093) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines